1-14 of 14
specialty pharmacy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Age-Stratified FVIII Consumption and Bleed Outcomes Before and After Switching to Rurioctocog Alfa Pegol in a Retrospective, Observational Study Using US Specialty Pharmacy Data

Maureen Watt, Scott Milligan
Journal: Blood
Blood (2019) 134 (Supplement_1): 2411.
https://doi.org/10.1182/blood-2019-124101
Published: 2019
Journal Articles

Barriers to the Use of Endari™ in an Urban Adult Sickle Cell Center

Ugochi Olivia Ogu, MD, Merin Thomas, NP, Florence Chan, PharmD, Gracy Sebastian, NP, Caterina P. Minniti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2287.
https://doi.org/10.1182/blood-2019-126666
Published: 2019
Journal Articles

High Dependence on Medicare and Foundation Grant Assistance Among Patients with Hematologic Malignancies Receiving Novel Oral Therapeutics

Erlene K. Seymour, MD, Lucius Daniel, Eva Pointer, MS, Stephen T. Smith, Charles A. Schiffer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 64.
https://doi.org/10.1182/blood-2019-128905
Published: 2019
Journal Articles

Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)

Louis M. Aledort, MD, Nisha Jain, MBBS,MD, Nanxin Li, Sangeeta Krishnan, PharmD, Benjamin Hagberg, Jun Su, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3514.
https://doi.org/10.1182/blood-2018-99-114905
Published: 2018
Journal Articles

Surveillance of Hemophilia in Indiana: A Preliminary Report

Amanda Okolo, MPH, John M Soucie, PhD, Scott D. Grosse, PhD, Chris Roberson, JD, MPH, Isaac Janson, PhD, Martha Allen, MSN, Amy Shapiro
Journal: Blood
Blood (2018) 132 (Supplement 1): 3516.
https://doi.org/10.1182/blood-2018-99-118849
Published: 2018
Journal Articles

A Novel Approach to Immune Tolerance Induction in Hemophilia Α with Factor VIII Inhibitor

Courtney D. Thornburg, MD, Jonathan M. Ducore, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5042.
https://doi.org/10.1182/blood-2018-99-119800
Published: 2018
Journal Articles

Increasing Ideal Coagulation Factor Dosing in the Pediatric Emergency Department: A Quality Improvement Study

Meghan Jackson, DO, Michael A Storey, PharmD, MS, Michael Dunn, MD, Amy L. Dunn, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2093.
https://doi.org/10.1182/blood.V130.Suppl_1.2093.2093
Published: 2017
Journal Articles

Predictors of Ponatinib Therapy Duration Among Real-World Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients in the US

Michael J. Mauro, MD, Lisa J. McGarry, MPH, Stephanie Lustgarten, PhD, Hui Huang, PhD MBA
Journal: Blood
Blood (2016) 128 (22): 3081.
https://doi.org/10.1182/blood.V128.22.3081.3081
Published: 2016
Journal Articles

Trends in Financial Toxicity for Patients of a Community Cancer Clinic

Cherupolil R. Santhosh-Kumar, MD, Stephanie Struve, CSW, Sue Freier, CSW
Journal: Blood
Blood (2015) 126 (23): 2124.
https://doi.org/10.1182/blood.V126.23.2124.2124
Published: 2015
Journal Articles

Exposure to New Therapies and Treatment Delay in Multiple Myeloma: Experience from a Safety Net Hospital

Timothy O'Brien, MD, Barbara Ruda, RN, Andrew Cluckey, MDcal student
Journal: Blood
Blood (2015) 126 (23): 5615.
https://doi.org/10.1182/blood.V126.23.5615.5615
Published: 2015
Journal Articles

Real-World Ponatinib Prescribing Patterns and Outcomes in US Patients

Michael J. Mauro, MD, Lisa J. McGarry, MPH, Mo Yang, PhD, Stephanie Lustgarten, PhD, Hui Huang, MBA, PhD
Journal: Blood
Blood (2015) 126 (23): 1591.
https://doi.org/10.1182/blood.V126.23.1591.1591
Published: 2015
Journal Articles

Real-World Prescribing Patterns with Ponatinib Among New and Ongoing US Patients

Lisa J McGarry, MPH, Greg Wolfe, PharmD, Ann Steagall, BSN, RN, OCN, Hui Huang, PhD MBA
Journal: Blood
Blood (2014) 124 (21): 5521.
https://doi.org/10.1182/blood.V124.21.5521.5521
Published: 2014
Journal Articles

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma

Henry J Henk, PhD, Satyin Kaura, MEng, MBA, Zeba M. Khan, PhD, April Teitelbaum
Journal: Blood
Blood (2012) 120 (21): 4688.
https://doi.org/10.1182/blood.V120.21.4688.4688
Published: 2012
Journal Articles

A Retrospective Review of Erythrocyte Stimulating Agents (ESA) Usage in Pharmacy Claims Data.

Scott A Lust, RPh, Milayna Subar, MD, Richard Faris, PhD, DPh, Wenlong Lin, MS, S. Jay Weaver, PharmD, MPH, Lorraine Tully, RHIT
Journal: Blood
Blood (2009) 114 (22): 900.
https://doi.org/10.1182/blood.V114.22.900.900
Published: 2009